Our data from both mice and humans uncovered that ASNS enhanced the immunogenicity of lung cancer cells and reshaped the immune microenvironment in metastatic TdLNs to modulate CD8+T cell infiltration in the tumor in situ. This evidence concerns the gene CD8A and lung cancer.